Efficacy of oral levofloxacin monotherapy against low-risk FN in patients with malignant lymphoma who received chemotherapy using the CHOP regimen

The safety and feasibility of oral fluoroquinolone monotherapy in patients with low-risk febrile neutropenia (FN) were demonstrated in recent studies. Levofloxacin (LVFX) is a commonly prescribed antibiotic; however, evidence for its efficacy against FN is limited. Therefore, in this study, we retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mogi, Ai, Sasaki, Hidenori, Nakashima, Yuta, Chinen, Shotaro, Ishizu, Masanao, Tanaka, Toshihiro, Takata, Tohru, Takamatsu, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596912/
https://www.ncbi.nlm.nih.gov/pubmed/32779614
http://dx.doi.org/10.3960/jslrt.20008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596912/
https://www.ncbi.nlm.nih.gov/pubmed/32779614
http://dx.doi.org/10.3960/jslrt.20008

Ejemplares similares